lebrikizumab (101)							9165

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVTLRESGPA LVKPTQTLTL TCTVSGFSLS AYSVNWIRQP PGKALEWLAM  50

IWGDGKIVYN SALKSRLTIS KDTSKNQVVL TMTNMDPVDT ATYYCAGDGY 100

YPYAMDNWGQ GSLVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY 150

FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTKTYT 200

CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL FPPKPKDTLM 250

ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV 300

VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP 350

PSQEEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG 400

SFFLYSRLTV DKSRWQEGNV FSCSVMHEAL HNHYTQKSLS LSLGK      445

Light chain / Chaone lygire / Cadena ligera

DIVMTQSPDS LSVSLGERAT INCRASKSVD SYGNSFMHWY QQKPGQPPKL  50

LIYLASNLES GVPDRFSGSG SGTDFTLTIS SLQAEDVAVY YCQQNNEDPR 100

TFGGGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV 150

QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV 200

THQGLSSPVT KSFNRGEC                                    218

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-95	145-201	259-319	365-423

	22??-95??	145??-201??	259??-319??	365??-423??

Intra-L	23?-92?	138?-198?



	23???-92???	138???-198???



Inter-H-L	132-218?	132??-218???



Inter-H-H	224-224??	227-227??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

295, 295??

CAS		953400-68-5

Description

immunoglobulin G4-kappa, anti-[Homo sapiens interleukin 13 (IL13,
IL-13)], humanized monoclonal antibody;

gamma4 heavy chain [humanized VH (Homo sapiens IGHV2-70*01 (82.80%)
-(IGHD)-IGHJ6*01) [8.7.12] (1-118) -Homo sapiens IGHG4*01 hinge S10>P
(119-445)], (132-218?)-disulfide with kappa light chain (1'-218')
[humanized V-KAPPA (Homo sapiens IGKV4-1*01 (79.20%) -IGKJ4*01) [10.3.9]
(1?-111?) -Homo sapiens IGKC*01 (112?-218?)];
(224-224":227-227")-bisdisulfide dimer 

immunoglobuline G4-kappa, anti-[Homo sapiens interleukine 13 (IL13,
IL-13)], anticorps monoclonal humanisy; 

chaone lourde gamma4 [VH humanisy (Homo sapiens IGHV2-70*01 (82.80%)
-(IGHD)-IGHJ6*01) [8.7.12] (1-118) -Homo sapiens IGHG4*01 charniire
S10>P (119-445)], (132-218?)-disulfure avec la chaone lygire kappa
(1'-218') [V-KAPPA humanisy (Homo sapiens IGKV4-1*01 (79.20%) -IGKJ4*01)
[10.3.9] (1?-111?) -Homo sapiens IGKC*01 (112?-218?)]; dimire
(224-224":227-227")-bisdisulfure 

inmunoglobulina G4-kappa, anti-[interleukina 13 de Homo sapiens (IL13,
IL-13)], anticuerpo monoclonal humanizado; 

cadena pesada gamma4 [VH humanizada (Homo sapiens IGHV2-70*01 (82.80%)
-(IGHD)-IGHJ6*01) [8.7.12] (1-118) -Homo sapiens IGHG4*01 bisagra S10>P
(119-445)], (132-218?)-disulfuro con la cadena ligera kappa (1'-218')
[V-KAPPA humanizada (Homo sapiens IGKV4-1*01 (79.20%) -IGKJ4*01)
[10.3.9] (1?-111?) -Homo sapiens IGKC*01 (112?-218?)]; dnmero
(224-224":227-227")-bisdisulfuro 

	

WHO 

International Nonproprietary Names Programme	

15/07/2009

p. 1/1



		

